475 related articles for article (PubMed ID: 32392110)
21. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
22. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
[TBL] [Abstract][Full Text] [Related]
23. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.
Abdi F; Quinn JF; Jankovic J; McIntosh M; Leverenz JB; Peskind E; Nixon R; Nutt J; Chung K; Zabetian C; Samii A; Lin M; Hattan S; Pan C; Wang Y; Jin J; Zhu D; Li GJ; Liu Y; Waichunas D; Montine TJ; Zhang J
J Alzheimers Dis; 2006 Aug; 9(3):293-348. PubMed ID: 16914840
[TBL] [Abstract][Full Text] [Related]
24. Role of connexins in neurodegenerative diseases (Review).
Xing J; Xu C
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
[TBL] [Abstract][Full Text] [Related]
25. Biomarker discovery in neurodegenerative diseases: a proteomic approach.
Shi M; Caudle WM; Zhang J
Neurobiol Dis; 2009 Aug; 35(2):157-64. PubMed ID: 18938247
[TBL] [Abstract][Full Text] [Related]
26. Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in Alzheimer's disease.
Grela A; Turek A; Piekoszewski W
Clin Chem Lab Med; 2012 Feb; 50(8):1297-304. PubMed ID: 22868793
[TBL] [Abstract][Full Text] [Related]
27. Searching for reliable premortem protein biomarkers for prion diseases: progress and challenges to date.
Ma D; Li L
Expert Rev Proteomics; 2012 Jun; 9(3):267-80. PubMed ID: 22809206
[TBL] [Abstract][Full Text] [Related]
28. Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis.
Chen S; Lu FF; Seeman P; Liu F
Neurochem Res; 2012 Dec; 37(12):2805-13. PubMed ID: 22926577
[TBL] [Abstract][Full Text] [Related]
29. Proteomics: a paradigm shift.
Kalia A; Gupta RP
Crit Rev Biotechnol; 2005; 25(4):173-98. PubMed ID: 16419616
[TBL] [Abstract][Full Text] [Related]
30. Genes and the environment in neurodegeneration.
Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
[TBL] [Abstract][Full Text] [Related]
31. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
32. Histone Methylation Regulation in Neurodegenerative Disorders.
Basavarajappa BS; Subbanna S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
[TBL] [Abstract][Full Text] [Related]
33. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
[TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease.
Wang S; Kojima K; Mobley JA; West AB
EBioMedicine; 2019 Jul; 45():351-361. PubMed ID: 31229437
[TBL] [Abstract][Full Text] [Related]
35. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
[TBL] [Abstract][Full Text] [Related]
36. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.
Cilento EM; Jin L; Stewart T; Shi M; Sheng L; Zhang J
J Neurochem; 2019 Nov; 151(4):397-416. PubMed ID: 30474862
[TBL] [Abstract][Full Text] [Related]
37. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins.
Butterfield DA; Kanski J
Mech Ageing Dev; 2001 Jul; 122(9):945-62. PubMed ID: 11348660
[TBL] [Abstract][Full Text] [Related]
38. Proteomics applications in prion biology and structure.
Moore RA; Faris R; Priola SA
Expert Rev Proteomics; 2015 Apr; 12(2):171-84. PubMed ID: 25795148
[TBL] [Abstract][Full Text] [Related]
39. Redox control of protein degradation.
Pajares M; Jiménez-Moreno N; Dias IHK; Debelec B; Vucetic M; Fladmark KE; Basaga H; Ribaric S; Milisav I; Cuadrado A
Redox Biol; 2015 Dec; 6():409-420. PubMed ID: 26381917
[TBL] [Abstract][Full Text] [Related]
40. Evolving Relevance of Neuroproteomics in Alzheimer's Disease.
Lista S; Zetterberg H; O'Bryant SE; Blennow K; Hampel H
Methods Mol Biol; 2017; 1598():101-115. PubMed ID: 28508359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
